^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Vx-001

    i
    Associations
    News

    Trials

    Company:
    Vaxon Biotech
    Drug class:
    Tumor-associated antigen inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Efficacy Study of Vx001 Vaccine in NSCLC Patients (NCT01935154)
    Phase 2
    Vaxon Biotech
    Completed
    Last update posted :
    06/19/2019
    Initiation :
    08/01/2012
    Primary completion :
    01/01/2017
    Completion :
    01/01/2017
    TERT
    |
    Vx-001